Meyer, Katharina
Ling, King-Hwa http://orcid.org/0000-0002-3968-7263
Yeo, Pei-Ling
Spathopoulou, Angeliki http://orcid.org/0000-0001-9239-6222
Drake, Derek
Choi, Jaejoon http://orcid.org/0000-0002-6695-2157
Aron, Liviu
Garcia-Corral, Mariana
Ko, Tak
Lee, Eunjung Alice http://orcid.org/0000-0002-6574-9261
Tam, Jenny M.
Perlis, Roy H.
Church, George M.
Tsai, Li-Huei
Yankner, Bruce A. http://orcid.org/0009-0008-8982-225X
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of Mental Health (RO1MH113279, RF1-AG048029, RO1MH113279, RO1MH113279, RO1MH113279, RO1MH113279, RO1MH113279, RO1MH113279, RF1-AG048029, RO1MH113279)
U.S. Department of Health & Human Services | NIH | National Institute of Mental Health
The Ludwig Foundation, The Robert and Renee Belfer Family Foundation
U.S. Department of Health & Human Services | NIH | National Institute of Mental Health
U.S. Department of Health & Human Services | NIH | National Institute of Mental Health
U.S. Department of Health & Human Services | NIH | National Institute of Mental Health
U.S. Department of Health & Human Services | NIH | National Institute of Mental Health
U.S. Department of Health & Human Services | NIH | National Institute of Mental Health
U.S. Department of Health & Human Services | NIH | National Institute of Mental Health
U.S. Department of Health & Human Services | NIH | National Institute of Mental Health
U.S. Department of Health & Human Services | NIH | National Institute of Mental Health
U.S. Department of Health & Human Services | National Institutes of Health (RF1-AG048029)
Article History
Received: 4 April 2023
Revised: 27 July 2023
Accepted: 25 October 2023
First Online: 8 November 2023
Competing interests
: GMC is a cofounder and senior advisor for GCTherapeutics, Inc., which uses transcription factors for therapeutics. The other authors declare no competing interests.